Skip to main content
. Author manuscript; available in PMC: 2018 May 4.
Published in final edited form as: Mech Ageing Dev. 2016 Jan 4;158:62–69. doi: 10.1016/j.mad.2015.12.005

Fig. 6.

Fig. 6

Effects of sirtinol on hCMV-induced ROS production in low passage WI-38 cells (30PD). Serum starved young WI-38 cells (30PD) were mock infection treated, hCMV infection alone (MOI 0.01), or pretreated with sirtinol at indicated concentrations added 2h before hCMV inoculation (MOI 0.01), and then were harvested at 4 dpi for ROS measurement by Flow cytometry analysis using probe H2DCFDA (% of ROS production shown on the Y axis). Data were obtained from three independent experiments. ##P<0.01, vs Mock infection group;*P<0.05, vs hCMV infection alone group.